Who We Are
Who we are
2engage is a multidisciplinary regulatory disclosure and creative agency offering a full range of capital markets, digital, video and print stakeholder communications. We help companies better engage with their investors, employees and customers through the multichannel production of SEC reporting, regulatory compliance, and creative storytelling
publications. Our customized solutions incorporate the latest trends to inform and enlighten your audience.
Let our team get to work for yours and help tell your story.
Project Managers
From concept development to post-production, we meticulously handle every aspect of your project. Our EDGAR/XBRL project managers have the vast and deep experience to ensure that all SEC reporting requirements are met accurately and timely.
Designers
Concepts and capabilities mean nothing without execution. Our powerhouse designers push creative boundaries to bring strategies to life through engaging and compelling content and visuals.
Focused on Solutions and Results
Our strategic thinking and creative communication skills help you engage and connect in the following areas

- Annual Reports
- Proxy Statements
- Sustainability Reports
- Prospectus
- Offering Memorandums
- Mutual Funds

- EDGAR Filings
- XBRL
- Section 16 Filings
- Newswire

- Online Annual Reports
- Online Proxy Statements
- ESG Sustainability Reports
- Diversity, Equity & Inclusion Reports
- Websites and Microsites
- Interactive PDFs and Marketing Collateral
- Animation including 3D
- Video

- Mobile Apps (Marketing)
- Mobile Apps (Investor)
Virtual Data and Room Capabilities
Collaboration
- Document Repository
- Proxy Statements
- Corporate Reporting
- Investment Raising
- Due Diligence
Fund Management
- Fund Reporting
- Private Equity
- Fund Raising
- Hedge Fund
Raising Business Capital
- Private Investment in Public Equity (Pipe)
- Private Placement Memorandum
- Corporate Reporting
- Fund Raising
- Debt Financing
Governance
- Board Communications
- Compliance/Sox
Investment Banking
- M&A Buy Side
- Proxy Statements
- M&A Sell Side
- IPO
- Bankruptcy/Restructuring
Life Sciences
- Biotech Licensing
- Cleantech
- Clinical Study